Persistent Head and Neck Cancer Following First-Line Treatment.

Following first-line treatment of head and neck cancer (HNC), persistent disease may require second-line treatment. All patients with HNC treated between 2008 and 2016 were included. Second-line treatment modalities and survival of patients were analyzed.